Development and validation of a quantitative assay based on tandem mass spectrometry

Annals of Clinical Biochemistry

Volumn 48, Issue 2, 2011, Pages 97-111

  Honour, John W ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; HOSPITAL LABORATORY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ANALYTIC SAMPLE PREPARATION METHODS; ANIMALS; CHROMATOGRAPHY, LIQUID; HUMANS; LABORATORIES, HOSPITAL; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 79953004927     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010176     Document Type: Review

References (74)

1. Taylor PJ. High-performance liquid chromatography-mass spectrometry in the clinical laboratory. Ther Drug Monit 2005;27:689-93 (Pubitemid 44391716)
2. Chace DH, Barr JR, Duncan MW, et al. Mass spectrometry in the clinical laboratory: general principles and guidance: proposed guideline. Document C50P. Pennsylvania: Clinical and Laboratory Standards, 2007
3. Anderson NL. Counting the proteins in plasma. Clin Chem 2010;56: 1775-6
4. Fredline VF, Kovacs EM, Taylor PJ, Johnson AG. Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. Clin Chem 1999;45:659-64 (Pubitemid 29220327)
5. Kumar V, Barnidge DR, Chen LS, et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 2010;56:306-13
6. Ghomashchi F, Bollinger JG, Gelb MH. Facile preparation of leukotrienes C(4), D(4) and E(4) containing carbon-13 and nitrogen-15 for quantification of cysteinyl leukotrienes by mass spectrometry. J Label Comp Radiopharm 2007;50:729-733
7. Yang WC, Regnier FE, Sliva D, Adamec J. Stable isotope-coded quaternization for comparative quantification of estrogen metabolites by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008;870:233-40
8. Napoli KL. Organic solvents compromise performance of internal standard (ascomycin) in proficiency testing of mass spectrometry-based assays for tacrolimus. Clin Chem 2006;52:765-6
9. Korecka M, Solari SG, Shaw LM. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther Drug Monit 2006;28:484-90 (Pubitemid 44191893)
10. Taylor PJ, Brown SR, Cooper DP, et al. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem 2005;51:1890-3 (Pubitemid 41368182)
11. O'Halloran S, Ilett KF. Evaluation of a deuterium-labeled internal standard for the measurement of sirolimus by high-throughput HPLC electrospray ionization tandem mass spectrometry. Clin Chem 2008;54:1386-9
12. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharm Biomed Anal 2007;44:342-55 (Pubitemid 46880094)
13. Nováková L, Vlcková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta 2009;656:8-35
14. Gao H, Williams J, Carrier S, Brummel CL. Bioanalytical solutions to acetonitrile shortages. Bioanalysis 2010;2:1627-40
15. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:22-34
16. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2198-207
17. de Jong WH, Graham KS, van der Molen JC, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem 2007;53:1684-93 (Pubitemid 47340066)
18. Kostiainen R, Kauppila TJ. Effect of eluent on the ionization process in liquid chromatography-mass spectrometry. J Chromatogr A 2009;1216:685-99
19. Keevil BG, Lockhart SJ, Cooper DP. Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay. J Chromatogr B Analyt Technol Biomed Life Sci 2003;794:329-35. (Pubitemid 37101010)
20. Apfel A, Fischer S, Goldberg G, Goodley PC, Kuhlmann FE. Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. J Chromatogr A 1995;712:177-90
21. Foltz RL, Edom RW. Problems and solutions in quantitative determination of drugs and metabolites in physiological specimens by LC-MS/MS. J Mass Spectrom Soc Jpn 1998;46:235-9
22. Bakhtiar R, Majumdar TK. Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry. J Pharmacol Toxicol Methods 2007;55:262-78 (Pubitemid 46436521)
23. Sillén H, Magnell N. Screening ionisation and chromatography conditions for quantitative LC/MS methods. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:3581-8
24. Covey TR, Thomson BA, Schneider BB. Atmospheric pressure ion sources. Mass Spectrom Rev 2009;28:870-97
25. Kebarle P, Verkerk UH. Electrospray: from ions in solution to ions in the gas phase, what we know now. Mass Spectrom Rev 2009;28:898-917
26. Robb DB, Blades MW. State-of-the-art in atmospheric pressure photoionization for LC/MS. Anal Chim Acta 2008;627:34-49
27. Liu S, Griffiths WJ, Sjövall J. On-column electrochemical reactions accompanying the electrospray process. Anal Chem 2003;75:1022-30 (Pubitemid 36232463)
28. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem 2005;38:319-27 (Pubitemid 40342862)
29. 2002/657/EC. Commission decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Commun 2002;L22:8-36
30. McEnroe RJ, Burritt MF, Powers DM, Rheinheimer DW, Wallace BH. Interference testing in clinical chemistry. Approved guideline. Document EP7. Pennsylvania: Clinical and Laboratory Standards Institute, 2005
31. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4 (Pubitemid 36751088)
32. Mei H, Hsieh Y, Nardo C, et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun Mass Spectrom 2003;17:97-103 (Pubitemid 36019888)
33. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 2005;38:328-34 (Pubitemid 40342863)
34. Gosetti F, Mazzucco E, Zampieri D, Gennaro MC. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J Chromatogr A 2010;1217:3929-37
35. Marchi I, Viette V, Badoud F, et al. Characterization and classification of matrix effects in biological samples analyses. J Chromatogr A 2010;1217:4071-8
36. Jemal M, Ouyang Z, Xia YQ. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed Chromatogr 2010;24:2-19
37. Xia YQ, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun Mass Spectrom 2009;23:2125-38
38. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE). J Pharm Biomed Anal 2005;37:359-67 (Pubitemid 40222308)
39. Ceglarek U, Werner M, Kortz L, et al. Preclinical challenges in steroid analysis of human samples. J Steroid Biochem Mol Biol 2010;121:505-12
40. Guo X, Bruins AP, Covey TR. Characterization of typical chemical background interferences in atmospheric pressure ionization liquid chromatography-mass spectrometry. Rapid Commun Mass Spectrom 2006;20:3145-50 (Pubitemid 44569795)
41. Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta 2008;627:71-81
42. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 1999;13:1175-1185 (Pubitemid 29285118)
43. Matuszewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J Chromatogr B Analyt Technol Biomed Life Sci 2006;830:293-300 (Pubitemid 43075465)
44. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019-30 (Pubitemid 36830428)
45. Leverence R, Avery MJ, Kavetskaia O, Bi H, Hop CE, Gusev AI. Signal suppression/enhancement in HPLC-ESI-MS/MS from concomitant medications. Biomed Chromatogr 2007;21:1143-50 (Pubitemid 350200893)
46. Homer N, Denham S, Stimson R, Watson D, Walker B, Andrew R. Analysis of cortisol by stable isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS): pitfalls of rapid LC-MS/MS of clinical samples. Presented at Society for Endocrinology BES 2010, Manchester, UK. Endocrine Abstracts 2010;21:P339
47. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005;51:1683-90 (Pubitemid 41233104)
48. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055-61 (Pubitemid 44271755)
49. Tai SS, Xu B, Welch MJ, Phinney KW. Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem 2007;388:1087-94 (Pubitemid 47150029)
50. Cawood ML, Field HP, Ford CG, et al. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin Chem 2005;51:1472-9 (Pubitemid 41060880)
51. Tholen DW, Kroll M, Astles JR, et al. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Document EP6. Pennsylvania: Clinical and Laboratory Standards Institute, 2003
52. Duxbury K, Owen L, Gillingwater S, Keevil B. Naturally occurring isotopes of an analyte can interfere with doubly deuterated internal standard measurement. Ann Clin Biochem 2008;45:210-2 (Pubitemid 351724596)
53. Tholen DW, Linnet K, Kondratovich M, et al. Protocols for determination of limits of detection and limits of quantitation; approved guideline. Document EP17. Pennsylvania: Clinical and Laboratory Standards Institute, 2004
54. Srinivas NR. Sensitivity enhancement in tandem liquid chromatographic mass spectrometric assays by summation of two transition ion pairs - perspectives. J Sep Sci 2009;32:483-6
55. Tholen DW, Kallner A, Kennedy JW, Krouwer JS, Meier K. Evaluation of precision performance of clinical chemistry devices; approved guideline. Document EP5. Pennsylvania: Clinical and Laboratory Standards Institute, 1999
56. Krouwer JS, Cembrowski GS, Tholen DW. A preliminary evaluation of quantitative clinical laboratory methods; approved guideline. Document EP10. Pennsylvania: Clinical and Laboratory Standards Institute, 1998
57. Krouwer JS, Tholen DW, Garber CC, et al. A method comparison and bias estimation using patient samples; approved guideline. Document EP9. Pennsylvania: Clinical and Laboratory Standards Institute, 1995
58. Sasse EA, Doumas BT, Miller WG, et al. How to define and determine reference intervals in the clinical laboratory; approved guideline. Document C28. Pennsylvania: Clinical and Laboratory Standards Institute, 2000
59. Jung B, Adeli K. Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem 2009;42:1589-95
60. Roberts WL, Rockwood AL, Bunker AM, Kushnir MM, Meikle AW. Limitations of the Hoffman approach to determine pediatric reference intervals for two steroids. Clin Biochem 2010;43:933-4
61. Guidance for Industry. Bioanalytical Method Validation. USA: Centre for Drug Evaluation and Research, US Department of Health and Social Services, Food and Drug Administration
62. Yang Z,Wang S. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants. J Immunol Methods 2008;336:98-103
63. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem 2007;53:1827-34 (Pubitemid 47509677)
64. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 2006;52:1120-6 (Pubitemid 43794425)
65. Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 2005;19:401-7
66. Napoli KL, Hammett-Stabler C, Taylor PJ, et al. Multi-center evaluation of a commercial kit for tacrolimus determination by LC/MS/MS. Clin Biochem. 2010;43:910-20
67. Kushnir MM, Ray JA, Rockwood AL, et al. Rapid analysis of 25-hydroxyvitamin D(2) and D(3) by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am J Clin Pathol 2010;134:148-56
68. Vogeser M. Instrument-specific matrix effects of calibration materials in the LC-MS/MS analysis of tacrolimus. Clin Chem 2008;54:1406-8
69. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009;46:79-81. Erratum in: Ann Clin Biochem 2009;46:434
70. Oberacher H, Pavlic M, Libiseller K, et al. On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study. J Mass Spectrom 2009;44:485-93
71. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-13
72. Bhasin S, Zhang A, Coviello A, et al. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders. Steroids 2008;73:1311-7
73. Vesper HW, Bhasin S,Wang C, et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 2009;74:498-503. Erratum in: Steroids 2009;74:791
74. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods 2009;347:3-11